Skip to main content
MTD logo

Mettler-Toledo International Inc. (MTD) Stock: Price, Forecast & Analyst Target

Mettler-Toledo International Inc. (MTD) — MoonshotScore 93/100 (Exceptional band), calculated Nov 18, 2026. Price $1705.66 (-1.82%), as of the Nov 19, 2026 trading session; market cap $33.9B. Expected results Feb 4, 2027.

Educational signal · not a buy or sell recommendation · How to read this

$1705.66 −$31.60 (-1.82%) Market Cap $33.9B

Mettler-Toledo International Inc. · MTD · NYSE · Healthcare · Medical - Diagnostics & Research

Research dated 2026-09-12: Mettler-Toledo sells precision instruments, inspection systems, software and related services to laboratories, manufacturers, logistics operators and food retailers. The case depends on whether that broad demand base and strong cash generation can sustain premium margins while carrying a capital structure with far more debt than cash.

Price as of Nov 19, 2026

Key Statistics

93 of 100

MoonshotScore v2 · Mettler-Toledo International (MTD)

Exceptional
Business Quality Elite (96)
Financial Safety Sound (62)
Valuation Rich (38)
Growth Durability Compounding (81)
Momentum Surging (93)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Elite quality and durable growth, but an expensive valuation; the market is already moving on it. Business Quality: Elite; Financial Safety: Sound; Valuation: Rich; Growth Durability: Compounding; Momentum: Surging.

  • quarterly revenue $1.03B (Q3 FY2025, quarter ended Sep 2025)
  • EPS beat 0 of the last 4 reports
  • expected results Feb 4, 2027

Helping: business quality, durable growth, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for MTD (57 recorded, newest six shown)
RecordedScoreBand
92Exceptional
92Exceptional
92Exceptional
92Exceptional
93Exceptional
93Exceptional

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$1705.66
Change on the day-1.82%
52-week range$1023.05–$1806.58
Market capitalisation$33.9B—
Price / earnings (trailing)37.03
Shares traded on the day127.2K
Beta (volatility vs the S&P 500)1.17

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 19, 2026: low $1,032, high $1,739, latest $1,706. $1,739 $1,032 high $1,739 Oct 17, 2025 Nov 19, 2026 · $1,706 $1,349Oct 17, 2025$1,416Oct 31, 2025$1,403Nov 14, 2025$1,477Nov 28, 2025$1,394Dec 12, 2025$1,420Dec 26, 2025$1,485Jan 9, 2026$1,406Jan 23, 2026$1,374Feb 6, 2026$1,378Feb 20, 2026$1,210Mar 6, 2026$1,204Mar 20, 2026$1,260Apr 2, 2026$1,341Apr 17, 2026$1,267May 1, 2026$1,032May 15, 2026$1,181May 29, 2026$1,131Jun 12, 2026$1,264Jun 26, 2026$1,296Jul 10, 2026$1,327Jul 24, 2026$1,429Aug 7, 2026$1,395Aug 21, 2026$1,345Sep 4, 2026$1,392Sep 18, 2026$1,486Oct 2, 2026$1,622Oct 16, 2026$1,675Oct 30, 2026$1,739Nov 13, 2026

Point at or tab to any week for its close.

Other perspectives

Council score for Mettler-Toledo International (MTD): perspectives

Some lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.

5-Factor Breakdown

Business Quality Strong
Financial Safety Moderate
Valuation Weak
Growth Durability Strong
Momentum Strong

Legends Council

5 lenses, 5 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Favorable read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Neutral read
Moon AI lens (model) Neutral read

Read on: Nov 19, 2026

Munger's Mindset

Balance Sheet & Valuation

Financial Health Neutral
Margin of Safety Overvalued
Profit Margin Strong
Revenue Growth Neutral
Debt/Equity Negative
Gross Margin Moderate

Read on: Nov 19, 2026

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

One of these lenses reads this company less favourably than the MoonshotScore does: Munger lens (margin of safety). Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.

The Munger lens reads the current price as overvalued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Mettler-Toledo International (MTD), and what does it report?

Short answer · as of

Mettler-Toledo is not primarily a clinical diagnostics developer.

It supplies the tools used to weigh, measure, analyze, inspect, label and trace materials and products, with LabX software managing data generated by laboratory instruments.

Reported revenue is organized around laboratory, industrial and retail products and services. Laboratory is the largest contributor, industrial is substantial, and retail is much smaller; the customer base therefore extends well beyond healthcare into food production, chemicals, logistics, electronics and academic research.

2 · Latest results

What do the latest results show for Mettler-Toledo International (MTD)?

Short answer · as of

The most recent reported quarter, Q3 FY2025, carried revenue of $1.03B.

In the latest reported period, revenue, gross profit, operating profit and net income all increased from the comparable period. Gross profit advanced faster than operating expenses, lifting profitability, while revenue landed just shy of the prevailing estimate and reported earnings exceeded it.

The annual series shows revenue extending its recovery, though the latest gain in net income was comparatively restrained. Management has framed the remaining-year outlook around modest growth; that guidance is an expectation rather than an explanation for the margin improvement already recorded.

Where is operating spending going?

Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.

Period endRevenueR&DSG&AFMP standardized operating result
Sep 30, 2026Not availableNot availableNot availableNot available
Jun 30, 2026Not availableNot availableNot availableNot available
Mar 31, 2026Not availableNot availableNot availableNot available
Dec 31, 2025Not availableNot availableNot availableNot available
How to read these figures

Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q3 FY2025$1.03B$217M$10.57 (diluted)
Q4 FY2025$1.13B$286M$13.98 (diluted)
Q1 FY2026$947M$169M$8.33 (diluted)
Q2 FY2026$1.03B$233M$11.55 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Mettler-Toledo International (MTD)?

Short answer

Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.

Cash generation is the principal financial strength. Operating cash flow remained positive throughout the displayed history, reached the strongest level in the latest period, and consistently exceeded capital spending by a wide margin; trailing profitability and quality screens also remain strong.

The balance-sheet constraint is leverage rather than operating burn. Debt greatly exceeds cash and investments, the cash balance declined across the reported window, and liquidity ratios provide only a modest near-term cushion. Any sustained weakening in laboratory or industrial purchasing would make continued cash conversion more important for meeting obligations.

Data-derived red flags

  • Inconsistent delivery — missed Wall Street EPS estimates in 0 of the last 4 reported quarters.
  • Rich valuation — a P/E of 37.03 runs well above the Healthcare sector’s ~21.70x, leaving little room for a miss.
4 · What to check next?

What should you watch next at Mettler-Toledo International (MTD)?

Short answer · as of

The next earnings report is expected on Feb 4, 2027.

At the coming earnings release, watch whether revenue returns to clearing consensus after the latest narrow shortfall while earnings preserves its run of positive surprises. Gross-margin retention will show whether the recent operating improvement is durable rather than confined to a favorable period.

Cash conversion deserves equal attention: operating cash flow should continue to cover capital spending comfortably, while the cash-to-debt gap should stop widening. Management’s modest growth framing and the rising longer-range revenue and earnings estimates set a clear confirmation test for demand across laboratory and industrial products.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The newest quarter held here (Q3 FY2025) was filed Nov 7, 2025 — 12 months ago.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Mettler-Toledo International compare with its peers?

Short answer

Mettler-Toledo International's score ranks tied for 2nd of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Compared with laboratory-focused instrument makers, Mettler-Toledo combines analytical tools with industrial weighing, product inspection, logistics measurement and fresh-food retail systems. Its largest business still serves laboratories, but the industrial operation gives the company meaningful exposure to factory quality control and material handling rather than research budgets alone.

The relevant comparison is therefore precision-workflow breadth, software and service support, margin quality and cash conversion—not a drug or diagnostic pipeline. Retail adds another distinct demand channel, though its revenue contribution is far smaller than the laboratory and industrial operations.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
IDEXX Laboratories, Inc. (IDXX) Same industry, near in market value$689.65 Nov 19, 2026$54.3B96 5-pillar Nov 18, 2026
Mettler-Toledo International (MTD) — this page$1705.66$33.9B93
DexCom, Inc. (DXCM) Named competitor$80.19 Nov 19, 2026$29.9B93 5-pillar Nov 18, 2026
Medpace Holdings, Inc. (MEDP) Same industry, near in market value$646.87 Nov 18, 2026$18.1B92 5-pillar Nov 18, 2026
Illumina, Inc. (ILMN) Same industry, near in market value$210.01 Nov 18, 2026$31.8B84 5-pillar Nov 18, 2026
Agilent Technologies, Inc. (A) Named competitor$175.34 Nov 19, 2026$49.4B83 5-pillar Nov 18, 2026
Alcon Inc. (ALC) Named competitor$74.52 Nov 19, 2026$35.8B80 5-pillar Nov 18, 2026
Quest Diagnostics Incorporated (DGX) Same industry, near in market value$258.99 Nov 19, 2026$28.5B74 5-pillar Nov 18, 2026
ICON Public Limited Company (ICLR) Same industry, near in market value$190.36 Nov 19, 2026$14.3B73 5-pillar Nov 18, 2026
IQVIA Holdings Inc. (IQV) Named competitor$257.84 Nov 18, 2026$42.5B71 5-pillar Nov 18, 2026
Labcorp Holdings Inc. (LH) Same industry, near in market value$370.78 Nov 18, 2026$30.1B71 5-pillar Nov 18, 2026
Revvity, Inc. (RVTY) Same industry, near in market value$151.59 Nov 19, 2026$16.9B71 5-pillar Nov 18, 2026
Charles River Laboratories International, Inc. (CRL) Same industry, near in market value$327.93 Nov 19, 2026$15.7B70 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Healthcare stocks

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$1350.00 – $1930.00
Consensus target
$1611.67
Median target
$1587.50

Consensus record · Captured .

Measured against a quoted price of $1705.66 (as of Nov 19, 2026).

Insider activity

Form 4 records via FMP · Of the newest 60 records, those within the last 180 days, newest dated Nov 12, 2026

Transactions
59
Identified insiders
16
Purchases
0
Sales
7
Other transactions
52

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held MTD in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported MTD in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Mettler-Toledo International (MTD)?

Read these with our analysis →

Mettler-Toledo International Healthcare Stock: Key Questions Answered

The last 2 questions are answered from this page's own dated data, not from the research.

What does LabX do within Mettler-Toledo’s laboratory offering?

LabX manages and analyzes data produced by Mettler-Toledo laboratory instruments, linking the company’s precision hardware to customers’ digital laboratory workflows.

Why do Mettler-Toledo product inspection systems matter outside laboratories?

Metal detection, X-ray inspection, checkweighing, imaging and track-and-trace systems connect Mettler-Toledo to production quality control. Demand for these products follows manufacturing and food-processing activity rather than laboratory spending alone.

Which Mettler-Toledo product group contributes the most revenue?

Laboratory products and services are the largest contributor, followed by industrial products and services. Retail weighing and related systems form a considerably smaller operation.

Can Mettler-Toledo’s cash generation offset its debt load?

Recent operating cash flow has comfortably exceeded capital spending, providing meaningful debt-service capacity. Debt nevertheless stands far above cash and investments, so the durability of that cash conversion remains central.

What is the MTD stock price today?

The last price recorded for Mettler-Toledo International Inc. (MTD), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the MTD price target?

The analyst consensus price target for Mettler-Toledo International Inc. (MTD), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 25 figures on this page — 1 from SEC filings and earnings calls, 21 from Financial Modeling Prep (FMP), 2 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-12), by section of the research

  • Summary at the top of the page: Business description; Revenue by segment; Operating cash flow by quarter (USD millions); Cash, investments and debt; Trailing twelve-month ratio set
  • 1. What is Mettler-Toledo International (MTD), and what does it report?: Sector / industry (provider taxonomy); Business description; Revenue by segment
  • 2. What do the latest results show for Mettler-Toledo International (MTD)?: Quarterly income statement (USD thousands); Annual revenue and net result (USD millions); Reported versus estimated, last 8 quarters; Management outlook — dated call excerpts; Most recent periodic reports
  • 3. What are the financial strengths and risks for Mettler-Toledo International (MTD)?: Operating cash flow by quarter (USD millions); Cash, investments and debt; Cash and investment components; Cash and short-term investments over time (USD millions); Cash decline over the reported window; Cash against market value; Trailing twelve-month ratio set; Distress and quality screens; Revenue by segment
  • 4. What should you watch next at Mettler-Toledo International (MTD)?: Next earnings report; Reported versus estimated, last 8 quarters; Analyst revenue and earnings estimates (average); Management outlook — dated call excerpts; Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Cash and short-term investments over time (USD millions); Cash, investments and debt
  • 5. How does Mettler-Toledo International compare with its peers?: Business description; Sector / industry (provider taxonomy); Revenue by segment; Trailing twelve-month ratio set; Operating cash flow by quarter (USD millions)
  • FAQ: What does LabX do within Mettler-Toledo’s laboratory offering?: Business description
  • FAQ: Why do Mettler-Toledo product inspection systems matter outside laboratories?: Business description; Revenue by segment
  • FAQ: Which Mettler-Toledo product group contributes the most revenue?: Revenue by segment; Business description
  • FAQ: Can Mettler-Toledo’s cash generation offset its debt load?: Operating cash flow by quarter (USD millions); Cash, investments and debt; Cash and investment components; Cash against market value
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.